A Study to Assess YH002 in Combination with YH001 in Subjects with Advanced Solid Tumors

NCT05169697 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: A:YH002+YH001
DRUG: B:YH002+YH001
DRUG: YH002+YH001

Sponsor

Eucure (Beijing) Biopharma Co., Ltd